Enovis Corp. (ENOV)
24.63
+0.36
(+1.48%)
USD |
NYSE |
Jan 15, 12:48
Enovis SG&A Expense (TTM): 1.057B for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Repligen Corp. | 276.62M |
| Twist Bioscience Corp. | 246.98M |
| Perspective Therapeutics, Inc. | 31.53M |
| InfuSystem Holdings, Inc. | 66.30M |
| Xtant Medical Holdings, Inc. | 74.03M |